Clinical trial
Prevalence of Drug-resistant Hiv-1 Strains in Patients Experiencing Virologic Failure.(MULTIVIR2025)
NCT06842706 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence of Drug-resistant Hiv-1 Strains in Patients Experiencing Virologic Failure.(MULTIVIR2025)
- Lead sponsor
- ANRS, Emerging Infectious Diseases
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- April 30, 2025
- Completion date
- March 31, 2026
- Enrollment
- 800 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infection